2016, Number 2
<< Back
Medisur 2016; 14 (2)
Ewing's sarcoma of short bones. A case report
Martínez ÁDR, Pomar DLS, Cruz CY
Language: Spanish
References: 13
Page: 232-236
PDF size: 143.82 Kb.
ABSTRACT
Ewing's sarcoma is a malignant tumor that primarily
affects children and adolescents. Nearly 95% of
these sarcomas occur between the ages of 5 to 25
years. It is more common in males and extremely
rare among blacks. It presents most often in the
diaphyses of long bones, the ribs and flat bones,
such as the scapula and pelvis. We present the case
of a 37 year-old woman with a tumor in the left hand.
The amputation of the first and second fingers was
performed as first-line treatment. The biopsy
revealed a Ewing's sarcoma. Subsequently, the
patient underwent chemotherapy regimen. This case
is of interest given the unusual location of the tumor.
REFERENCES
Denny CT. Gene rearrangements in Ewing´s sarcoma. Cancer Invest. 1996 ; 14 (1): 83-88.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) [Internet]. Washington: NCCN; 2015. [ cited 19 Dic 2015 ] Available from: http://www.nccn.org/professionals/drug_compend ium/content/changes_archive.asp?Panel_ID=47.
Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, et al. Ewing´s sarcoma family of tumors: current management. Oncologist. 2006 ; 11 (5): 503-9.
Hernández González EH, Mosquera Betancourt G, Quintero Martínez O, Hernández Cabezas I. Sarcoma de Ewing. AMC [revista en Internet]. 2013 [ cited 19 Dic 2015 ] ; 17 (5): [aprox. 15p]. Available from: http://scielo.sld.cu/scielo.php?pid=S1025-025520 13000500012&script=sci_arttext.
Millán Escalona E, Corona Pérez R, Ríos Gutiérrez N. Sarcoma de Ewing en paciente masculino. Rev Cubana Med Gen Integr [revista en Internet]. 2010 [ cited 9 Feb 2016 ] ; 26 (3): [aprox. 9p]. Available from: http://scieloprueba.sld.cu/scielo.php?script=sci_a rttext&pid=S0864-21252010000300015&lng.
Fergal Kelleher C, Thomas DM. Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours. Clin Sarcoma Res. 2012 ; 2 (1): 6.
European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014 ; 25 Suppl 3: Siii102-12.
Van Maldegem AM, Hogendoorn PC, Hassan AB. The clinical use as prognostic factors in Ewing sarcoma. Clin Sarcoma Res. 2012 ; 2 (1): 7.
Buzaid AC, Cotait F, Rocha CM. Manual de Oncología Clínica de Brasil. 7ª ed. São Paulo: Dendrix; 2013.
Instituto Nacional de Cáncer. Sarcoma de Swing [Internet]. Bethesda, MD: Instituto Nacional de Cáncer; 2015. [ cited 5 Ene 2016 ] Available from: http://www.cancer.gov/espanol/tipos/hueso/pro/tr atamiento-ewing-pdq.
Bernstein ML, Devidas M, Lafreniere D, Souid AK, Meyers PA, Gebhardt M, et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children’s Cancer Group Phase II Study 9457—a report from the Children’s Oncology Group. J Clin Oncol. 2006 ; 24 (1): 152-9.
Bacci G, Forni C, Longhi A, Ferrari S, Donati D, De Paolis M, et al. Long-term outcome for patients with non metastatic Ewing’s sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004 ; 40 (1): 73-83.
Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V, et al. The value of local treatment in patients whith primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 2010 ; 116 (2): 443-50.